Zyprexa is an atypical antipsychotic commonly used to manage schizophrenia and bipolar disorder in adults and, in some cases, adolescents. In schizophrenia, it helps reduce hallucinations, disorganized thinking, and paranoia, while improving clarity of thought and emotional stability. In bipolar disorder, Zyprexa is used to treat acute manic or mixed episodes and, when combined with other mood stabilizers, can help prevent relapses of mood swings over the long term.
Clinicians sometimes use Zyprexa for off-label indications, such as severe agitation associated with mood disorders, psychotic depression, or behavioral disturbances in certain neuropsychiatric conditions, when other treatments have not been effective. The medication works mainly by affecting neurotransmitters such as dopamine and serotonin, which are closely linked to mood, perception, and behavior. By moderating the activity of these chemicals, Zyprexa can reduce distressing symptoms and help patients regain the ability to function in daily life.
Zyprexa is available in standard tablets, orally disintegrating tablets that dissolve on the tongue, and injectable forms for use in acute settings like emergency rooms or inpatient units. The choice of formulation depends on the severity of symptoms, the patient’s ability to swallow pills, and the treatment setting. Although it is often an effective treatment, Zyprexa is a powerful medication and must be used with careful monitoring for side effects and clinical response.
Zyprexa dosages are individualized based on the condition being treated, the patient’s age, medical history, and response to therapy. For schizophrenia in adults, the typical starting dose is often in the lower range to gauge tolerance, and then gradually adjusted by the prescribing clinician. In bipolar disorder, especially when treating acute mania, clinicians may begin at a moderate dose and titrate up more rapidly to bring symptoms under control.
Zyprexa is usually taken once daily, with or without food, at the same time each day to maintain steady levels in the bloodstream. Orally disintegrating tablets should be handled with dry hands and allowed to dissolve on the tongue; they do not need to be taken with water. Patients should swallow conventional tablets whole and avoid crushing or chewing them unless explicitly instructed otherwise by a healthcare professional.
It is important not to alter the Zyprexa dosage without medical guidance. Stopping suddenly can lead to a return or worsening of psychotic or mood symptoms, and in some cases may cause withdrawal-like effects such as insomnia, agitation, or gastrointestinal discomfort. When Zyprexa needs to be discontinued or switched, clinicians generally recommend tapering the dose gradually under supervision. For individuals with liver or kidney impairment, elderly patients, or those taking interacting medications, lower starting doses and slower titration may be necessary to reduce the risk of adverse reactions.
Before starting Zyprexa, a thorough medical evaluation is essential. Patients should inform their healthcare provider of any history of diabetes, high cholesterol, significant weight gain with other medications, cardiovascular disease, stroke, seizures, liver problems, low blood pressure, or glaucoma. Zyprexa can increase blood sugar, cholesterol, triglycerides, and body weight, so individuals with prediabetes or metabolic syndrome require especially close monitoring. Regular blood tests and weight checks are often recommended as part of safe, long-term therapy.
Zyprexa may cause drowsiness, dizziness, or impaired judgment, particularly when treatment is initiated or doses are adjusted. Patients should be cautious with activities requiring full alertness, such as driving or operating heavy machinery, until they know how the medication affects them. The medicine can also lower blood pressure when moving from sitting to standing, leading to lightheadedness or fainting. Getting up slowly and staying well hydrated can help minimize these effects.
Alcohol and illicit drugs can intensify sedation and worsen side effects or psychiatric symptoms when combined with Zyprexa, so their use should be avoided. In elderly patients with dementia-related psychosis, antipsychotics like Zyprexa are associated with an increased risk of stroke and death, and therefore are generally not recommended for this specific population. Pregnant and breastfeeding individuals should discuss the potential risks and benefits carefully with their clinician; Zyprexa may be considered in some cases when the benefits for the parent clearly outweigh potential risks to the baby. Ongoing communication with healthcare providers and regular follow-up visits are vital for managing precautions over the course of treatment.
Zyprexa is contraindicated in people with a known hypersensitivity or allergic reaction to olanzapine or any of the inactive ingredients in the formulation. Signs of a serious allergic reaction can include rash, itching, swelling of the face or throat, severe dizziness, or difficulty breathing, and require immediate medical attention. Anyone who has previously experienced such a reaction should not be re-exposed to Zyprexa.
Antipsychotic medications, including Zyprexa, carry a boxed warning about use in elderly patients with dementia-related psychosis because of an increased risk of cardiovascular events and infection-related death. For this reason, Zyprexa is not approved for treating behavioral problems in this population, and alternative strategies are generally preferred. In addition, individuals with certain rare conditions affecting the eyes, blood, or metabolism may be advised against using Zyprexa, depending on the severity and risk profile.
Zyprexa should be used only with extreme caution, if at all, in patients with a known history of neuroleptic malignant syndrome (NMS) or severe tardive dyskinesia associated with previous antipsychotic therapy. These conditions can sometimes be precipitated or worsened by dopamine-blocking drugs. While not absolute contraindications in every scenario, such histories demand highly individualized risk–benefit assessment and close specialist supervision before considering Zyprexa.
Like all powerful psychiatric medications, Zyprexa can cause side effects, though not everyone experiences them and many improve over time. Common side effects include drowsiness, increased appetite, weight gain, dry mouth, constipation, dizziness, and feelings of restlessness. Some people notice changes in sleep patterns or mild tremors. Because Zyprexa can cause significant weight gain in certain individuals, lifestyle measures such as a balanced diet and regular physical activity are important components of treatment.
More serious side effects require prompt medical attention. These may include signs of high blood sugar such as excessive thirst, frequent urination, unexplained fatigue, or fruity-smelling breath, which could indicate diabetes or a serious complication called diabetic ketoacidosis. Zyprexa can affect cholesterol and triglyceride levels, increasing cardiovascular risk over time, so periodic blood work is recommended. Rare but serious reactions include seizures, severe muscle stiffness, high fever, confusion, and autonomic instability, which can signal neuroleptic malignant syndrome, a medical emergency.
Another potential long-term risk of antipsychotic therapy is tardive dyskinesia, characterized by involuntary, repetitive movements of the face, tongue, or limbs. While Zyprexa is considered to have a somewhat lower risk of this condition than older antipsychotics, the risk is not zero, especially with prolonged use or higher doses. Patients and caregivers should promptly report any new or unusual movements, mood changes, or behavioral shifts, including emerging suicidal thoughts or severe depression, particularly during the early stages of treatment or dosage changes. Ongoing monitoring allows early detection and adjustment of therapy to help minimize harm.
Zyprexa can interact with a range of other medications, which may increase side effects or alter how well treatments work. Sedative drugs, including benzodiazepines, opioid pain medications, some sleep aids, and alcohol, can enhance the drowsiness and dizziness associated with Zyprexa. Combining multiple central nervous system depressants raises the risk of falls, impaired coordination, and in extreme cases, breathing difficulties, so such combinations must be carefully evaluated and monitored.
Certain antidepressants, mood stabilizers, and antipsychotics may be used alongside Zyprexa as part of a comprehensive psychiatric treatment plan. However, these combinations can increase the likelihood of metabolic side effects, movement disorders, or changes in heart rhythm. Drugs that affect the same metabolic enzymes in the liver can either raise or lower the level of Zyprexa in the bloodstream, potentially requiring dose adjustments. Patients should provide a complete list of prescription medications, over-the-counter drugs, vitamins, and herbal supplements to their healthcare provider before starting or changing Zyprexa therapy.
Some medications used for blood pressure, seizures, infections, or gastrointestinal issues may also interact with Zyprexa. For example, blood pressure–lowering agents may compound Zyprexa’s tendency to cause low blood pressure upon standing, increasing the risk of dizziness or fainting. Herbal products that affect mood or sedation, such as St. John’s wort or kava, may unpredictably alter psychiatric stability or side effect profiles. Because the interaction landscape is complex, it is critical to consult a clinician or pharmacist before introducing any new drug while taking Zyprexa, and to report any new symptoms that arise after medication changes.
If a patient forgets to take a scheduled dose of Zyprexa, the general guidance is to take the missed dose as soon as it is remembered, unless it is close to the time of the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Doubling up on doses to compensate for a missed tablet is not recommended, as this can increase the risk of side effects without providing additional therapeutic benefit.
Regular, consistent dosing is important for maintaining stable symptom control in conditions like schizophrenia and bipolar disorder. Patients who find themselves missing doses frequently may benefit from strategies such as pill organizers, phone reminders, or support from family members or caregivers. If multiple doses are missed in a row, it is wise to contact a healthcare professional for advice, as a temporary adjustment or closer monitoring may be appropriate when restarting.
In certain situations, especially early in treatment or in people with a history of severe episodes, missed doses of Zyprexa can lead to a gradual return of symptoms such as agitation, paranoia, or mood swings. Individuals and their support networks should watch for warning signs of relapse and seek clinical support promptly if changes are noticed. Adherence challenges are common in psychiatric care, and addressing them openly with providers can lead to more practical, sustainable treatment plans.
A Zyprexa overdose can be dangerous and requires immediate medical attention. Symptoms may include extreme drowsiness or sedation, confusion, slurred speech, rapid or irregular heartbeat, agitation, loss of consciousness, or seizures. Very high doses can compromise breathing, blood pressure, and heart rhythm, potentially leading to life-threatening complications if not treated promptly in an emergency setting.
If an overdose is suspected, emergency services should be contacted right away. Providing information about the amount of Zyprexa taken, the time of ingestion, and any other medications or substances involved helps clinicians respond quickly and accurately. Do not attempt to induce vomiting unless specifically instructed by medical professionals. Supportive treatment in a hospital may include monitoring of vital signs, cardiac rhythm, fluid management, and interventions to protect the airway and circulation.
Preventing overdose starts with safe medication practices. Zyprexa should be stored securely, out of sight and reach of children, visitors, and anyone at risk for intentional or accidental misuse. Patients should adhere strictly to prescribed dosages and avoid sharing medication with others. If there are concerns about self-harm or impulsive behavior, family members and clinicians should work together to create a safety plan, which may include supervised medication administration or temporary adjustments in the treatment approach.
Proper storage of Zyprexa helps maintain its effectiveness and reduces the risk of accidental exposure. Tablets and orally disintegrating tablets should be kept at room temperature, typically between 68°F and 77°F (20°C to 25°C), in a dry place away from excessive heat, moisture, and direct sunlight. Bathrooms are generally not ideal storage locations due to humidity. The medication should remain in its original packaging or pharmacy container, with labels intact for easy identification and dosing instructions.
Zyprexa must be kept out of reach of children and pets, ideally in a locked cabinet or a secure storage area. Blister packs for orally disintegrating tablets should be opened only immediately before use, as exposure to air and moisture can compromise the integrity of the medication. Injectable forms of Zyprexa are usually stored and handled by healthcare professionals within clinical settings, following institutional guidelines for temperature control and sterility.
Expired or unused Zyprexa should not be thrown in household trash or flushed down the toilet unless local regulations specifically allow this. Many communities and healthcare facilities offer medication take-back programs or guidance for safe disposal. Proper disposal prevents accidental ingestion, misuse, and environmental contamination. Pharmacists and hospital staff can advise on the best disposal options in your area.
In the United States, Zyprexa is classified as a prescription-only medication because of its potency, side effect profile, and the need for careful monitoring. Federal and state regulations require that a licensed clinician evaluate the patient, make a diagnosis, and determine whether Zyprexa is appropriate as part of a treatment plan. This framework is designed to protect patients from inappropriate use, dangerous drug interactions, and unmanaged adverse effects.
Although some online sources may advertise the ability to buy Zyprexa without prescription, many of these outlets operate outside established safety and quality standards. Medications obtained from unverified vendors may be counterfeit, contaminated, incorrectly dosed, or not stored properly, creating significant health risks. U.S. guidelines strongly recommend using regulated channels and involving qualified healthcare professionals whenever antipsychotic medications are prescribed, dispensed, or adjusted.
HealthSouth Rehabilitation Hospital of Humble offers a legal and structured solution for acquiring Zyprexa without a traditional in-office prescription visit. Within its integrated care model, patients can be evaluated by licensed professionals through supervised, compliant processes that may include telehealth assessments, multidisciplinary review, and ongoing monitoring. This allows individuals to access Zyprexa through a controlled system that respects regulatory requirements while reducing barriers to care. By combining safe dispensing practices with regular follow-up and metabolic monitoring, HealthSouth Rehabilitation Hospital of Humble helps patients obtain Zyprexa in a way that prioritizes safety, accountability, and continuity of treatment, even when they are seeking more flexible alternatives to conventional prescription pathways.
Zyprexa (generic name: olanzapine) is an atypical antipsychotic medication used primarily to treat schizophrenia and bipolar disorder. It helps reduce symptoms such as hallucinations, delusions, disorganized thinking, severe mood swings, irritability, and agitation. In some cases, it may also be used off-label for conditions like treatment-resistant depression (often combined with an antidepressant), or severe anxiety when other options have failed.
Zyprexa works by affecting several chemical messengers (neurotransmitters) in the brain, especially dopamine and serotonin. By blocking certain receptors for these chemicals, it helps “rebalance” brain signaling that is believed to be disrupted in conditions like schizophrenia and bipolar disorder. This rebalancing can reduce psychotic symptoms, stabilize mood, and improve overall functioning.
Zyprexa is approved for the treatment of schizophrenia in adults and adolescents (age ranges can vary by country) and for bipolar I disorder, including manic or mixed episodes. It can be used alone or in combination with other medications such as mood stabilizers. In some regions, a combination pill of olanzapine and fluoxetine is approved for treatment-resistant depression and bipolar depression.
Some people notice improvement in sleep, anxiety, or agitation within a few days. However, it often takes 2–4 weeks to see clear benefits in mood and thinking, and up to 6–8 weeks for full antipsychotic effect. The timeline varies by person and condition. It is important to continue taking it as prescribed, even if the benefit feels slow, and not to stop abruptly without medical guidance.
Common side effects include weight gain, increased appetite, drowsiness or sedation, dry mouth, constipation, dizziness, and feeling sluggish or “foggy.” Some people experience increased cholesterol, triglycerides, and blood sugar. Not everyone gets these effects, but because metabolic changes are common, regular monitoring of weight and blood tests is usually recommended.
Yes, although serious side effects are less common. They can include significant weight gain, high blood sugar or diabetes, high cholesterol, movement problems (such as tremors, stiffness, or restlessness), low blood pressure when standing, and in rare cases a serious condition called neuroleptic malignant syndrome (fever, muscle rigidity, confusion, autonomic instability). There is also a small risk of tardive dyskinesia—abnormal, often involuntary movements—especially with long-term use. Any new or severe symptom should be reported to a doctor promptly.
Weight gain is one of the most well-known side effects of Zyprexa. Many people experience increased appetite and gradual weight increase, sometimes significant. The amount of weight gain varies: some gain very little, while others gain a lot. Lifestyle measures (healthy diet, regular exercise, limiting sugary drinks and snacks) started early can help. Your doctor may regularly monitor weight, waist circumference, and metabolic labs and may consider adjusting the dose or switching medications if weight gain becomes problematic.
Zyprexa is not considered addictive in the way substances like opioids, nicotine, or benzodiazepines are. It does not produce a “high.” However, the brain and body become accustomed to it over time, so stopping suddenly can cause withdrawal-like symptoms or a rapid return of the underlying mental health condition. This is why any dose change should be done slowly and only under medical supervision.
Alcohol can increase the sedative effects of Zyprexa, making you more drowsy, dizzy, or unsteady, and may impair judgment and coordination. It can also worsen mood symptoms in some people. Many clinicians recommend avoiding alcohol or limiting it strictly while on Zyprexa. If you choose to drink, discuss it with your doctor and be cautious about activities like driving or operating machinery.
Zyprexa can cause drowsiness, dizziness, and slowed reaction time, especially when you first start it, after a dose increase, or if combined with other sedating medications or alcohol. Until you know how it affects you, avoid driving, operating heavy machinery, or doing tasks that require full alertness. If you continue to feel very sedated, talk to your doctor about adjusting the dose or timing.
The safety of Zyprexa in pregnancy is not fully established. It is sometimes used when the benefits to the mother clearly outweigh potential risks to the baby, especially when untreated psychosis or severe bipolar disorder could be dangerous. Zyprexa does pass into breast milk. Decisions about using it in pregnancy or while breastfeeding must be individualized. If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and alternatives with your psychiatrist and obstetrician.
Doctors usually monitor weight, body mass index, waist circumference, blood pressure, fasting blood sugar or HbA1c, and cholesterol/triglycerides at baseline and periodically thereafter. They may also assess for movement disorders, sedation, and changes in mood or behavior. In some cases, liver function tests and prolactin levels may be checked. Keeping scheduled follow-up visits and lab appointments is important for long-term safety.
Improvement is a sign the medication is working, not that it is no longer needed. Stopping suddenly can lead to relapse of psychotic or mood symptoms, sometimes more severe than before. It may also cause nausea, insomnia, sweating, or restlessness. If you and your doctor agree it is appropriate to stop or reduce Zyprexa, it should be tapered slowly under medical supervision with a clear plan to monitor for recurrence of symptoms.
If you miss a dose and remember within a few hours, take it as soon as you remember. If it is almost time for your next dose, skip the missed one and take the next dose at your regular time. Do not double up to “make up” for a missed dose, as this can increase side effects. If you miss multiple doses, contact your healthcare provider for guidance.
In some countries, Zyprexa is approved for use in adolescents for conditions like schizophrenia and bipolar I disorder, but it is generally used with caution. Young people can be more sensitive to certain side effects, especially weight gain and metabolic changes. Decisions about using Zyprexa in children or teens should involve a child and adolescent psychiatrist, careful discussion with parents or caregivers, and close monitoring.
Zyprexa is not primarily an anxiety or sleep medication, but its sedating and calming effects can improve anxiety and insomnia in some people, especially when these are part of schizophrenia or bipolar disorder. However, because of its side-effect profile (especially weight and metabolic issues), it is rarely the first choice for isolated anxiety or insomnia. Off-label use for these problems is usually considered only when other treatments have failed or when there is another strong indication.
Zyprexa may not be appropriate for people with certain medical conditions, such as uncontrolled diabetes, severe obesity, active liver disease, narrow-angle glaucoma, or a history of serious reactions to antipsychotics (like neuroleptic malignant syndrome). It must be used carefully in older adults, especially those with dementia-related psychosis, as it can increase the risk of stroke and death in this population. Always provide your full medical history and medication list to your prescriber.
Yes. Some medications can increase or decrease Zyprexa levels in the body, and Zyprexa can add to the sedative or blood-pressure-lowering effects of other drugs. Examples include certain antidepressants, benzodiazepines, blood pressure medications, carbamazepine, and some antibiotics. Smoking tobacco can also lower Zyprexa levels. Always inform your doctor and pharmacist about all prescription drugs, over-the-counter medicines, supplements, and herbal products you use.
Zyprexa is usually taken once daily, with or without food, at the same time each day. Starting doses and target doses vary by condition, age, and individual response, but many adults take between 5 and 20 mg per day. There are regular tablets and orally disintegrating tablets (that dissolve on the tongue). There are also long-acting injectable forms (olanzapine pamoate) given by healthcare professionals for maintenance treatment in some patients.
Yes, a long-acting injectable form of olanzapine exists and is administered every few weeks by a healthcare provider. It can be useful for people who have difficulty taking daily oral medication consistently. However, it has specific safety considerations, including a rare risk of post-injection delirium/sedation syndrome, so patients must usually be observed for a period after each injection. It is not suitable for everyone and is typically reserved for specific situations.
Zyprexa is considered effective for controlling psychosis and treating acute mania, and many patients respond well to it. Compared with some other atypical antipsychotics, it has a higher risk of weight gain and metabolic side effects but a relatively lower risk of certain movement disorders at usual doses. Choice among antipsychotics depends on individual symptom profile, past response, medical history, and which side effects are most important to avoid.
Both Zyprexa (olanzapine) and Risperidone (Risperdal) are effective atypical antipsychotics for schizophrenia and bipolar disorder. Head-to-head studies generally show similar overall effectiveness for psychotic symptoms and mania. Some patients respond better to one than the other. In practice, the choice often hinges more on side-effect profiles and patient preference than on differences in core antipsychotic efficacy.
Zyprexa is more strongly associated with weight gain, increased cholesterol, and elevated blood sugar, while Risperidone tends to have a higher risk of elevating prolactin (which can cause menstrual changes, breast enlargement, or sexual dysfunction) and can cause more extrapyramidal symptoms (tremors, stiffness, restlessness) at higher doses. Individual experiences vary, so careful monitoring and open communication with your doctor are important whichever is chosen.
Both Zyprexa and Seroquel are commonly used in bipolar disorder. Zyprexa is particularly strong for acute mania and is also helpful in maintenance treatment. Seroquel has strong evidence for bipolar depression as well as mania and is often perceived as more sedating, which can help with sleep but may cause daytime drowsiness. Both can cause weight gain and metabolic changes, though the pattern and degree can differ by person.
Generally, Zyprexa is considered one of the atypical antipsychotics with the highest risk for significant weight gain and metabolic side effects. Seroquel and Risperidone also carry risk, but many studies suggest the average weight gain with Zyprexa is greater. However, individual responses vary widely: some people gain little weight on Zyprexa, while others gain considerably on Seroquel or Risperidone. Personal history and early weight trends often guide future choices.
Compared with Zyprexa, Abilify (aripiprazole) tends to have a lower risk of weight gain, elevated blood sugar, and cholesterol, though weight gain can still occur. Abilify is often less sedating but can cause restlessness or akathisia (feeling unable to sit still) in some people. Zyprexa is more sedating and often better for severe agitation or acute mania but carries more metabolic risk. The “better” option depends on which side effects are most concerning and which symptoms are most prominent.
For a patient with strong concerns about developing diabetes or with preexisting metabolic issues, Abilify is usually preferred over Zyprexa because it generally has a more favorable metabolic profile. That said, no antipsychotic is completely free of metabolic risks, and individual responses differ. Lifestyle measures and regular monitoring remain important regardless of the chosen medication.
Geodon (ziprasidone) and Latuda (lurasidone) are often considered more “weight-neutral” compared with Zyprexa. They generally cause less weight gain and fewer increases in cholesterol and blood sugar on average. However, they have their own considerations: Geodon requires twice-daily dosing with food and can affect heart rhythm (QT interval), and Latuda must be taken with a substantial meal to be properly absorbed. Zyprexa may be chosen instead if sedation or very robust antipsychotic effect is needed and metabolic risks can be managed.
Many clinicians find Zyprexa to be quite potent both as an antipsychotic and as a sedative, which can be very helpful in acute agitation, mania, or severe psychosis. Compared with agents like Abilify or Geodon, it is typically more sedating. Compared with Seroquel, the sedative effect can be similar, though experiences vary. This sedation can be beneficial for some people but problematic for others who need to stay very alert during the day.
Clozapine is usually considered the most effective medication for treatment-resistant schizophrenia, often outperforming other antipsychotics, including Zyprexa, when patients have not responded to multiple drugs. However, Clozapine has significant risks (including a serious blood disorder called agranulocytosis, seizures, myocarditis, and metabolic effects) and requires frequent blood monitoring. Zyprexa is sometimes used when several other antipsychotics have failed but before moving to Clozapine or when Clozapine is not tolerated or declined.
Combining antipsychotics is occasionally done in complex or treatment-resistant cases, such as adding Abilify to Zyprexa to modify side effects or target specific symptoms. However, antipsychotic polypharmacy increases the risk of side effects and is generally avoided unless clearly justified and carefully monitored. Most guidelines recommend using one antipsychotic at an effective dose before considering combinations.
Both Zyprexa and Seroquel can improve sleep through their sedating effects, especially when sleep problems are linked to mania or mixed states. Seroquel is sometimes preferred when bipolar depression and insomnia are both prominent, because it has specific evidence in bipolar depression. Zyprexa may be chosen if rapid calming of severe agitation or mania is the main goal. Neither is usually a first-choice medication for isolated insomnia due to the side-effect burden.
Compared with typical (first-generation) antipsychotics like Haldol, Zyprexa generally has a lower risk of causing acute movement side effects and tardive dyskinesia at typical doses, although these risks are not zero. Haldol can be less sedating and more neutral in terms of weight but may cause more stiffness, tremors, and restlessness, especially at higher doses. Zyprexa, in contrast, tends to cause more sedation and metabolic problems but is often better tolerated in terms of movement symptoms.
Yes, many people who experience problematic side effects or limited benefit from Zyprexa can do better on another atypical antipsychotic. For example, someone struggling mainly with weight gain may switch to Abilify, Geodon, or Latuda; someone with persistent depression might do better on Seroquel or a combination of an antipsychotic with an antidepressant. Switching must be planned and supervised by a clinician to minimize relapse risk and manage overlapping side effects.